DMAC logo

DiaMedica Therapeutics Inc.

DMAC
Healthcare|Biotechnology|US
$9.36
+0.32 (+3.54%)
DCF Value
$0.30
Tangible Book / Share
$0.71
Cash / Share
$0.81
Next Earnings Report
Nov 12, 2026
EPS est. -$0.20 · Revenue est. $13.5M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (1)

Dec 2026
Est. completion
P2P3Acute Stroke
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
NCT05065216n=728

Recent Press Releases

DiaMedica Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Business Update November 13, 2026
Nov 5, 2026 · Business Wire
DiaMedica Therapeutics Announces Enrollment of 200th Patient in ReMEDy2 Phase 2/3 Acute Ischemic Stroke Trial
Oct 22, 2026 · Business Wire
DiaMedica Therapeutics Provides Update on Fetal Growth Restriction Key Opinion Leader Webinar
Oct 19, 2026 · Business Wire
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction Featuring Early Phase 2 FGR Results
Sep 30, 2026 · Business Wire
DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences
Sep 2, 2026 · Business Wire
DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
Aug 10, 2026 · Business Wire

SEC Filings (49)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Aug 11, 2026S-8Employee stock planDocumentIndex
Aug 10, 202610-QQuarterly reportDocumentIndex
Aug 10, 20268-KMaterial eventDocumentIndex
May 21, 20268-KMaterial eventDocumentIndex
May 6, 202610-QQuarterly reportDocumentIndex
May 6, 20268-KMaterial eventDocumentIndex
Apr 1, 2026ARSAnnual report to holdersDocumentIndex
Apr 1, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 1, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 31, 20268-KMaterial eventDocumentIndex
Mar 30, 202610-KAnnual reportDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 6, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 5, 20268-KMaterial eventDocumentIndex
Dec 18, 20258-KMaterial eventDocumentIndex
Nov 13, 2025S-8Employee stock planDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Nov 7, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Oct 15, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Sep 4, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 27, 2025SC 13GPassive 5%+ stakeDocumentIndex
Aug 22, 2025EFFECTDocumentIndex
Aug 22, 2025424B2Offering prospectusDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
Aug 12, 2025S-3Shelf registrationDocumentIndex
Aug 12, 202510-QQuarterly reportDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
Aug 8, 2025EFFECTDocumentIndex
Aug 6, 20258-KMaterial eventDocumentIndex
Aug 1, 2025S-3Shelf registrationDocumentIndex
Jul 30, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Jul 30, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Jul 25, 2025DDocumentIndex
Jul 21, 20258-KMaterial eventDocumentIndex
Jul 17, 20258-KMaterial eventDocumentIndex
May 15, 20258-KMaterial eventDocumentIndex
May 13, 202510-QQuarterly reportDocumentIndex
May 13, 20258-KMaterial eventDocumentIndex